JP Morgan Chase
SPHS

JP Morgan Chase’s Sophiris Bio, Inc. SPHS Stock Holding History

JP Morgan Chase’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed – – 6180
2018
Q3 		$0 Sell
1
-87,767
-100% -$250K ﹤0.01% 6009
2018
Q2 		$247K Buy
87,768
+87,767
+8,776,700% +$261K ﹤0.01% 4483
2018
Q1 		$0 Sell
1
-23,400
-100% -$50.7K ﹤0.01% 5847
2017
Q4 		$53K Buy
23,401
+1,390
+6% +$3.03K ﹤0.01% 4883
2017
Q3 		$129K Sell
22,011
-1,593
-7% -$3.3K ﹤0.01% 4234
2017
Q2 		$138K Sell
23,604
-1
-0% -$2 ﹤0.01% 4081
2017
Q1 		$67K Buy
23,605
+5,652
+31% +$15.5K ﹤0.01% 4452
2016
Q4 		$50K Sell
17,953
-5,828
-25% -$16.5K ﹤0.01% 4551
2016
Q3 		$139K Buy
+23,781
New +$89.5K ﹤0.01% 3789
2016
Q2 		– Sell
-4,200
Closed -$7K – 5243
2016
Q1 		$7K Buy
+4,200
New +$7.41K ﹤0.01% 4329

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

JP Morgan Chase's SPHS Position: Q4 2018 in Review

JP Morgan Chase sold out of Sophiris Bio, Inc. (SPHS) in Q4 2018, closing a stake of 1 share.

JP Morgan Chase first reported a position in SPHS in Q1 2016 and held it in 10 quarters. The position peaked at $247K in Q2 2018. 31 funds tracked by Wall St. Rank hold SPHS as of Q4 2018.

  • JP Morgan Chase reported no remaining Sophiris Bio, Inc. position as of Q4 2018 after selling out during the quarter.
  • JP Morgan Chase sold 1 Sophiris Bio, Inc. share in Q4 2018.
  • JP Morgan Chase first reported a position in Sophiris Bio, Inc. in Q1 2016 and held it in 10 quarters.
  • JP Morgan Chase's Sophiris Bio, Inc. position peaked at $247K in Q2 2018.
  • 31 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2018.

Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.